CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹1,213 Cr | ₹864 Cr | ₹689 Cr | ₹383 Cr | ₹571 Cr |
What is the latest Capital Work in Progress ratio of CIPLA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹1,213 Cr |
| Mar2024 | ₹864 Cr |
| Mar2023 | ₹689 Cr |
| Mar2022 | ₹383 Cr |
| Mar2021 | ₹571 Cr |
How is Capital Work in Progress of CIPLA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,213 Cr | 40.31 | |
| Mar2024 | ₹864 Cr | 25.41 | |
| Mar2023 | ₹689 Cr | 79.99 | |
| Mar2022 | ₹383 Cr | -32.92 | |
| Mar2021 | ₹571 Cr | - | |
Compare Capital Work in Progress of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹100,381.3 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| MANKIND PHARMA | ₹84,227.3 Cr | 2% | -0.6% | -16.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.1% |
-6.3% |
-18.3% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses